Why the study?
Does chronic intravenous adriamycin induce low output heart failure and activate vasoconstrictor mechanisms in rabbits?
Does chronic intravenous adriamycin induce low output heart failure and activate vasoconstrictor mechanisms in rabbits?
Adriamycin administration in rabbits produces a reliable model of low output heart failure characterized by sequential activation of the renin-angiotensin and sympathetic nervous systems.
Answers are grounded in this paper and cite their sources.
Supports adriamycin rabbit model for staged neurohormonal activation in low-output HF; leaves open translation to human cardiomyopathy.
Chronic administration of intravenous adriamycin (1 mg·kg−1 twice weekly for 8 weeks) to rabbits resulted in a cardiomyopathy which was similar to that occurring in patients with adriamycin cardiotoxicity. We studied systemic and renal haemodynamics and the activation of vasoconstrictor mechanisms reflected by changes in plasma renin activity (PRA), noradrenaline (NA) and vasopressin (AVP) levels during the development of heart failure in this animal model. By 8 weeks cardiac failure was clearly established. At postmortem all animals had dilated hearts, pleural and pericardial effusions, ascites and hepatic congestion. Heart weights were increased (8.1 ± 0.7 g in treated animals n = 9 vs 6.0 ± 0.2 g in controls n = 9 p < 0.05). Cardiac output (measured by thermodilution) fell at 8 weeks from 799 ± 61 ml·min−1 to 624 ± 44 ml·min−1 (n = 6 p < 0.05) with a parallel fall in mean blood pressure from 85 ± 2 mmHg to 75 ± 4 mmHg. Total peripheral resistance rose in four of the six rabbits. Renal blood flow fell from 108 ± 4 ml·min−1 to 61 ± 6 ml·min−1 (p < 0.05) by 8 weeks. Renal vascular resistance increased in all animals. PRA increased from 5.1 ± 0.5 ng AI·ml−1·h−1 to 11.6 ± 2.6 ng AI·ml−1·h−1 by 4 weeks (p < 0.05) and remained elevated thereafter. Plasma NA did not change significantly by 4 weeks but approximately doubled by eight weeks (0.7 ± 0.1 pmol·ml−1 to 1.6 ± 0.2 pmol·ml−1). Vasopressin levels did not change significantly. These results suggest that vasoconstrictor mechanisms may be activated sequentially in heart failure with early activation of the renin-angiotensin system and later activation of the sympathetic nervous system. Adriamycin cardiomyopathy in the rabbit is a good model of low output heart failure which closely resembles the human condition and thus offers considerable potential for investigating the pathophysiology, pathogenic factors and newer therapeutic modalities.
No takes yet. Share an insight, caveat, or question.
Arnolda et al. (1985) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: